As a biotech startup, Loxo Oncology was in need of a clean design that communicated their vision and values. Shofsky developed a brand guide and full suite of branded materials, from logo to letterhead, business cards, website, trade show materials and more
Secure staging environments allowed Shofsky to thoroughly test and debug the site code and then send to Loxo Oncology for a streamlined review, feedback and approval process of the new website’s content, design, and functionality.
When Loxo Oncology was revamping their corporate lobby, Shofsky created a custom, multi-level and scientifically accurate art installation, as well as artistic abstractions of fundamental scientific concepts.
Tossing the outmoded industry standard of static graphics aside, Shofsky created a custom, mobile-friendly and easily updatable pipeline graphic that provided crucial drug program progress, at a glance. Custom development on front-end and back-end allowed for easy updates to drug programs with just a few clicks.
Prior to the acquisition by Eli Lilly and Loxo Oncology’s subsequent NASDAQ delisting, Shofsky created a custom IR site that improved on NASDAQ and BusinessWire’s IR service and gave Loxo Oncology a highly-functional IR site that prioritized financial data, event, PR and document security. Fully-customizable and self-hosted, it gave Loxo Oncology complete control over their Investor Relations experience, providing portability, a user-friendly design, and allowing them to maintain a cohesive brand.
By clicking “Submit,” I agree to the Terms of Service.
